20170406 Telix Logo.png
Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration
December 13, 2017 17:30 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...
20170406 Telix Logo.png
Telix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing Partnership
December 12, 2017 17:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and TOKYO, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development...
20170406 Telix Logo.png
Telix Pharmaceuticals Appointed Dr. Bernard Lambert as President of Telix Pharmaceuticals (US) Inc.
December 03, 2017 17:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...
20170406 Telix Logo.png
Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange
November 14, 2017 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...
20170406 Telix Logo.png
Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering
November 08, 2017 18:20 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and...
20170406 Telix Logo.png
Telix Pharmaceuticals and ANMI Partner for Prostate Cancer Imaging
October 23, 2017 19:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, Company), a clinical-stage biopharmaceutical company focused on the development...
20170406 Telix Logo.png
Telix Pharmaceuticals Limited Launches $50 Million Underwritten Initial Public Offering (ASX: TLX)
October 23, 2017 17:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, the Company), an Australian biopharmaceutical company focused on the development of diagnostic and...
20170406 Telix Logo.png
University of Melbourne and Telix Pharmaceuticals Establish Cancer Translational Research Partnership
October 17, 2017 17:18 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and...
20170406 Telix Logo.png
Telix Pharmaceuticals and CellSight Technologies Conclude Collaboration and License Agreement for VisAcT ImmunoPET Technology
September 19, 2017 21:46 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and SAN FRANCISCO, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, the Company) is pleased to announce the conclusion of a collaboration and licensing...
20170406 Telix Logo.png
Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited
September 17, 2017 18:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have been...